Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2010 Nov 3;126(1):221–226. doi: 10.1007/s10549-010-1235-y

Fig. 2.

Fig. 2

Change in median age-adjusted composite score from the assessment taken at the end of endocrine therapy (Y5) to the assessment taken approximately 1 year after completion of endocrine therapy (Y6) according to endocrine therapy received, showing significant improvement in cognition, as measured by the composite score, from Y5 to Y6